Frequencies of interleukin-5 mRNA-producing cells in healthy individuals and in immunoglobulin-deficient patients, measured by in situ hybridization
Open Access
- 1 September 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 81 (3) , 417-422
- https://doi.org/10.1111/j.1365-2249.1990.tb05349.x
Abstract
Interleukin‐5 (IL‐5) has previously been demonstrated to enhance immunoglobulin synthesis, especially IgA. Thus, it could be hypothesized that a defect production of IL‐5 may cause immunoglobulin deficiency. We have analysed the frequency of IL‐5 mRNA‐producing cells in healthy adults and in patients with common variable immunodeficiency or selective IgA deficiency. Unstimulated lymphocytes were rarely found to synthesize IL‐5 as measured by in situ hybridization. However, pokeweed mitogen and several other activating ligands induced the synthesis of IL‐5 mRNA in peripheral blood and spleen lymphocyte cultures. After pokeweed mitogen activation, the number of IL‐5 mRNA‐producing cells most often peaked on day 3 with a maximal frequency of around 1–2% of mononuclear cells. In a kinetic study we were unable to detect any peak frequency differences between healthy controls (mean 0.44%) and 20 patients (mean 0.58%), Thus, although IL‐5 has been reported to be an important regulator of IgA synthesis, a defect production does not seem to be the underlying mechanism in human immunoglobulin deficiency.Keywords
This publication has 34 references indexed in Scilit:
- B cell function in acquired “common-variable” hypogammaglobulinemia: Proliferative responses to lymphokinesClinical Immunology and Immunopathology, 1989
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication.The Journal of Experimental Medicine, 1988
- T Cell‐Replacing Factor (TRF)/Interleukin 5 (IL‐5): Molecular and Functional PropertiesImmunological Reviews, 1988
- Molecular and Cellular Biology of Eosinophil Differentiation Factor (Interleukin‐5) and its Effects on Human and Mouse B CellsImmunological Reviews, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- IgA2 ALLOTYPES DETERMINED BY RESTRICTION FRAGMENT LENGTH POLYMORPHISM IN IgA DEFICIENCY RE‐EXPRESSION OF THE SILENT A2m(2) ALLOTYPE IN THE CHILDREN OF IgA‐DEFICIENT PATIENTSInternational Journal of Immunogenetics, 1987
- Control of messenger RNA stabilityImmunology Today, 1987
- Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individualsNature, 1982
- SELECTIVE TRIGGERING OF HUMAN T AND B LYMPHOCYTES IN VITRO BY POLYCLONAL MITOGENSThe Journal of Experimental Medicine, 1974